Register for IPO Updates
US IPO Stats
IPO Industry Breakdown
Largest Global IPOs
Largest US IPOs
IPO News Archive
New Ways to Invest in IPOs - IPO ETFs
US IPO Weekly Recap: 4 IPOs price, Talend on top, Kadmon a flop
Analyst IPO Market Commentary
Four IPOs raised $315 million during the last week of the month, bringing July’s deal count to ten and signaling that IPO activity has not yet taken a vacation. Further evidence of a gradual tech IPO recovery materialized with cloud-based software provider Talend rocketing 42% higher on its debut, after pricing 13% above the midpoint. On the other hand, cash-burning drug maker Kadmon saw shares fall 19% on its opening day after pricing 33% below the midpoint, continuing the trend of
underperforming biotech IPOs
), which offers a next-generation data integration platform to enterprises, raised $94.5 million after pricing at $18, above the $15-$17 range. Though currently unprofitable, the company addresses a $16 billion market and has managed to secure big-name customers such as General Electric, Allianz and Citi. Talend projects steep revenue growth. Fellow technology companies
; +181% total return) and LINE (
; +14%) are the only other companies to price above the range this year.
), a specialty insurer led by former James River (
; 12/14 IPO; +63%) executives, climbed 15% on its debut. After upsizing the offering and pricing at the top of its range, the pure-play excess and surplus insurer raised $106 million (24% insider selling). The company has maintained an industry-leading adjusted combined ratio as well as an ROE above 15% during the same period. That said, while gross premiums written have increased, competition has put downward pressure on its average premiums.
), a biotech with an accumulated deficit of $677 million, was the year’s second-worst performing debut, trading down 19%, despite pricing 33% below its original midpoint. It closed even lower on Friday, for a -25% total return thus far. Its unusual capital structure may have turned off investors. Though it raised $75 million (53% insider buying) on the offering, it will need substantial additional capital in order to see its Phase 2 candidates through to commercialization.
), which sells at-home compression devices for vascular swelling, raised $40 million by offering 4 million shares at $10, after it hovered in day-to-day status for almost a month and slashed its price from the original $14-$16 range. Its heavy reliance on one product (>85% of sales), potential issues with Medicare reimbursement and uncertain scalability of its business model may have led to the valuation haircut needed to attract investors. While it finished the week up 13% at $11.26, it is still well below the initial range.
IPO Pricings Week of July 25th, 2016
Provides an open source data integration platform to enterprise customers.
Kinsale Capital Group (KNSL)
Property and casualty insurer providing excess and surplus insurance.
Tactile Systems Technology (TCMD)
Sells at-home compression therapy devices for vascular swelling.
Developing kinase inhibitors for autoimmune disease, fibrosis and solid tumors.
IPO Pipeline update
Five companies set terms this week, including BNP spin-off
; $464 million deal size) and big-box home furnishings retailer
At Home Group
; $130 million), both slated to price in the coming week. They were joined by three smaller deals: late-stage biotech
; $35 million), gastrointestinal biotech
; $15 million) and Wi-Fi antenna provider
; $14 million), all expected in August. The only initial filing came from
; $12 million), a micro-cap manufacturer of microwave electronic components.
IPO Market Snapshot
The Renaissance IPO Indices are market cap weighted baskets of newly public companies. After five weeks of ourperformance, the US IPO Index tied the S&P 500 this week as both indices fell 0.1%. Year-to-date, the IPO Index is down 3%, while the S&P 500 up 6%. Renaissance Capital's
(NYSE: IPO) tracks the index, and
top ETF holdings
include Alibaba (
), Synchrony Financial (
) and Citizens Financial Group (
). The Renaissance International IPO Index rose 3% this week for a YTD return of -4%, compared to the ACWX, which increased 1% this week for a YTD return of +2%. Renaissance Capital’s International
(NYSE: IPOS) tracks the index, and
top ETF holdings
include Recruit Holdings, NN Group and Aena S.A.
Keywords / Tickers:
Recently Priced IPOs
ETF Express Award:
ETFExpress awards are based on a 'peer review system' whereby readers - including institutional and high net worth investors as well as managers and other industry professionals at fund administrators, brokers, custodians and advisers - are invited to elect a 'best in class' in a series of categories via an online survey. In each category, the firms with the most votes at the end of the voting period are subject to a final review by ETFExpress's Senior Editorial team.
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the original cost. Investors should consider the investment objectives, risks, charges and expenses carefully before investing.
As stated in the Prospectus, the total annual operating expenses for the Fund was 3.48%. The Adviser has contractually agreed to keep net expenses from exceeding 2.50% of the Fund's average daily net assets for at least a year from the date of the Prospectus and for an indefinite period thereafter subject to annual re-approval of the agreement by the Board of Trustees.
An investor cannot invest directly in an index. Index returns do not represent Fund returns. The Index does not charge management fees or brokerage expenses, nor does the Index lend securities, and no revenues from securities lending were added to the performance shown.
Definitions: Net Asset Value (NAV) of the fund is calculated by dividing the total value of all the securities in its portfolio, less any liabilities, by the number of fund shares outstanding. Market Price is current value at which an asset or service can be bought or sold. Premium/Discount is provided to show the comparison of the daily net asset value (NAV) and the midpoint of the closing bid/ask for each of the funds.
Renaissance IPO Index® (IPOUSA)
is a stock market index based upon a portfolio of U.S.-listed newly public companies that includes securities prior to their inclusion in core U.S. equity portfolios.
Renaissance International IPO Index® (IPOXUS)
is a stock market index based upon a portfolio of newly public companies listed on non-U.S. exchanges.
The S&P 500® Index (SPX) is a stock market index which includes 500 U.S. listed companies and seeks to capture approximately 80% coverage of available U.S. market capitalization.
Risk Disclosure: Investments in the
Renaissance IPO ETF, symbol "IPO"
Renaissance International IPO ETF, symbol "IPOS"
(the "ETFs"), and the
Global IPO Fund, symbol "IPOSX"
(the "Mutual Fund") are subject to investment risk, including possible loss of the principal amounts invested. The ETFs and the Mutual Fund (the "Funds") invest in companies that have recently completed initial public offerings. These stocks are unseasoned equities lacking trading history, a track record of reporting to investors and widely available research coverage which many result in extreme price volatility. Due to a greater number of IPOs in certain segments, the Funds may also be subject to information technology and financial sector risk, small and mid-capitalization company risk, and, for the Renaissance International IPO ETF, emerging markets risk. The Funds may hold securities in the form of Depository Receipts, REITs, and Partnership Units which have greater risks than common shares. The strategies have high portfolio turnover and securities lending risks. The returns of the ETFs may not match the return of the respective indices. The ETFs are classified as non-diversified investment companies subject to concentration risk.
Prospectus: Investors should consider the investment objectives, risks, charges and expenses carefully before investing. For a prospectus and/or summary prospectus with this and other information, please visit
. Read the prospectus carefully before investing. Renaissance Capital Investments, Inc., distributor for the Mutual Fund. Foreside Fund Services, LLC, distributor for the ETFs, 1-866-486-6645.
Definitions: The Renaissance IPO Index® is a stock market index based upon a portfolio of U.S.-listed newly public companies that includes securities prior to their inclusion in core U.S. equity portfolios. The S&P 500® Index is a stock market index based on the market capitalizations of 500 large companies whose common stock is publicly traded on the NYSE or Nasdaq.
The information contained herein is proprietary and copyrighted. The media is welcome to use our information and ideas, provided that the following sourcing is included: Renaissance Capital - manager of IPO-focused ETFs.
The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO), the Renaissance International IPO ETF (symbol: IPOS), or the Global IPO Fund (symbol: IPOSX), may have investments in securities of companies mentioned.
Register for Updates
Renaissance Capital LLC is an SEC-registered investment adviser.
Renaissance Capital Investments, Inc. is a
-registered broker-dealer, and member of
© 2016 Renaissance Capital LLC. All rights reserved.